The pharmaceutical industry is entering the final phase of the Drug Supply Chain Security Act (DSCSA), with the FDA’s November 2024 deadline looming. The DSCSA mandates full implementation of a secure, electronic, and interoperable system for tracking and tracing prescription drugs across the U.S. supply chain. This law, enacted in 2013, aims to prevent counterfeit, […]
